z-logo
open-access-imgOpen Access
Prospective study of bethesda categories III and IV thyroid nodules: Outcomes and predictive value of BRAFV600E mutation
Author(s) -
Shiga Rappai Chirayath,
Praveen V Pavithran,
Nithya Abraham,
Vasantha Nair,
Nisha Bhavani,
Harish Kumar,
Usha Me,
Arun S Me
Publication year - 2019
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/ijem.ijem_635_18
Subject(s) - medicine , thyroid nodules , malignancy , indeterminate , atypia , prospective cohort study , bethesda system , thyroid , cytology , cytopathology , radiology , nodule (geology) , gynecology , pathology , paleontology , mathematics , pure mathematics , biology
Atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has emerged as the most controversial category because of its heterogeneity and inconsistent reporting. There is a definite paucity in data available from the Indian subcontinent about the outcome of nodules carrying Bethesda category III or Bethesda category IV diagnoses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here